Del Prato S, Kang J, Trautmann ME, Stewart J, et al. Efficacy and safety of once-monthly efpeglenatide in patients with type 2 diabetes: Results of a phase 2 placebo-controlled, 16-week randomized dose-finding study. Diabetes Obes Metab 2020 Mar 3. doi: 10.1111/dom.14020.
PMID: 32128957